Project Grant K23HL171954
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$157K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This $585,794 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a novel mobile phone technology to improve access to preeclampsia and hypertension detection. The project, awarded to Tele-Stethoscope Inc., a self-certified small disadvantaged business, seeks to demonstrate proof-of-concept that ordinary mobile phones can be used to diagnose preeclampsia and detect hypertension. The...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant will fund a 12-week proof-of-concept study testing a technology-delivered mindful walking intervention to reduce stress, increase physical activity, and lower blood pressure in Black women with hypertension. The project aims to address disparities in hypertension and physical activity rates among...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $708,678 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Wake Forest University Health Sciences. This grant will support a Sequential Multiple Assignment Randomized Trial (SMART) to evaluate interventions for improving food security and treatment adherence in patients with hypertension. The study aims to determine the most effective initial food insecurity intervention and subsequent support for...
This Project Grant award of $727,972.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) is funding a study to understand racial/ethnic disparities in clinician concordance with hypertension treatment guidelines and blood pressure control. The primary objectives are to: 1) evaluate the extent of racial disparity in hypertension treatment based on the 2017 AHA/ACC guidelines in the Southeastern U.S.; 2) investigate patient, provider, clinic, and...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,321,108 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to New York University School of Medicine to conduct transdisciplinary implementation research on a strategy called PT4A. PT4A integrates peer-based medication delivery, peer coaching, and health information technology to improve medication adherence and reduce blood pressure among patients with uncontrolled hypertension in Western Kenya. The study aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), aims to pilot test the effectiveness of a culturally tailored virtual reality (VR)-based stress management program in addressing intersectional stress and improving cardiovascular health outcomes among hypertensive Black women. The University of Miami will receive $165,807 over a 5-year period starting August 1, 2024 to conduct focus...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,314,024 Project Grant under CFDA 93.837 Cardiovascular Diseases Research to Weill Medical College of Cornell University to implement the "Coaching and Navigation by CHWs through Telehealth for High-Risk Hypertension" (CONNECT-HTN) intervention. The project aims to reduce death and hospitalization due to heart disease or stroke by connecting patients with severe hypertension to primary care resources and providing...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $2,256,023 to Arizona State University to develop a mobile app-based intervention to improve blood pressure medication adherence among Medicaid enrollees. The project, titled "Mobile Cued Adherence Therapy (MCAT): A Scalable Habit Formation Intervention to Improve Blood Pressure Medication Adherence Based on a Widely Used Smartphone...
HC Simulation LLC received a $236,969 National Science Foundation Project Grant under the Engineering program (CFDA 47.041) to develop a virtual population of older, Black patients with hypertension and comorbidities. The grant, awarded August 1, 2021 for a one-year period, will support the company's creation of a simulation platform to improve treatment development for this patient demographic. NSF's Engineering directorate seeks to advance innovation and excellence in engineering research...
This federal Project Grant award of $116,748.00, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to enhance the recipient's capability as a leader in patient-oriented cardiovascular research and mentorship at Washington University. The key products and services to be delivered under this grant include: 1) Conducting new advanced implementation research using the NHLBI-funded Hypertension Treatment in Nigeria...